DURECT focused on the development of pharmaceutical products based on its drug delivery technology platforms. .. Read more
DURECT focused on the development of pharmaceutical products based on its drug delivery technology platforms. .. Read more
1998
PublicAcquired by Bausch Health Companies Inc.NASDAQDRRX
News
Aug 14, 2025
Owler
Durect Corporation: Durect's revenue changed from $1.86M in Mar 2025 to $1.66M in Jun 2025
Aug 13, 2025
Nasdaq
Durect: Durect Posts Narrower Loss in Fiscal Q2
Jul 31, 2025
Benzinga
Durect: $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of DURECT Corporation (NASDAQ: DRRX)
May 14, 2025
Owler
Durect Corporation: Durect's revenue changed from $2.03M in Dec 2024 to $1.86M in Mar 2025
May 14, 2025
Yahoo
Durect: Durect: Q1 Earnings Snapshot
May 13, 2025
PR Newswire
Press Release: Durect : DURECT Corporation Reports First Quarter 2025 Financial Results and Provides Business Update
Mar 27, 2025
Seeking Alpha
Durect: DURECT outlines $20M Phase 3 trial for larsucosterol in alcohol-associated hepatitis
Mar 19, 2025
Marketscreener
Durect: DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update
Feb 04, 2025
Yahoo
Durect: DURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
Jan 28, 2025
StreetInsider
Press Release: Durect : DURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM Evidence
Durect Competitors
1
2
3
4
5
6
7
8
9
10